نتائج البحث 691-700 من 14957 لعملية البحث عن treatment resistant depression
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma. Scottsdale/Phoenix, Ariz. The purpose of this study is to evaluate ...
The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic information and surgical outcomes which ...
A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma. Rochester, Minn., ...
The purpose of this study is to evaluate how well bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell ...
Wasson, Ph.D. Psychologist. Jacksonville, FL. مناطق التركيز: Cognitive behavioral therapy, Acceptance and commitment therapy, Sleep disorders, Depression, ...
Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Using radiation techniques, such as intensity modulated radiotherapy to avoid ...
Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. ... resistance to 131I-MIBG and crizotinib. ... Treated, Advanced ...
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
... treatment protocol (FBT-PC) for PCP management of ... Treated with Dopamine Agonist Therapy ... depression. التصفّح دراسات سريرية. توجّه للصفحة 11 ...
NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.